Sigma takes legal action against Chemist Warehouse


Sigma is set to commence legal proceedings against the My Chemist/Chemist Warehouse group

Sigma Healthcare Limited said in a statement today that it has been in ongoing discussions relating to the operation of certain aspects of the current supply agreement with the group.

It says that My Chemist/Chemist Warehouse rejected offers of mediation and binding arbitration which had been proposed during these discussions.

“As a satisfactory resolution has not been reached, Sigma has now decided to commence legal proceedings against MC/CW,” says Sigma.

These proposed proceedings relate to the My Chemist/Chemist Warehouse group’s stated intention to acquire certain products from an alternate CSO Wholesaler.

Sigma maintains that under the existing agreement, My Chemist/Chemist Warehouse is not entitled to do this.

“Remedies to be sought by Sigma include declarations and injunctions for specific performance of the agreement,” Sigma says.

“If MC/CW acts in accordance with their stated intention, the impact on Sigma’s EBIT is expected to be approximately $5m – $10m per annum.

“While Sigma remains confident of its position, this action, combined with a continuation of the subdued start to the financial year, may mean that current year underlying EBIT could be up to 5% below FY2016/7 (subject to the outcome of the proposed proceedings).

“Ongoing legal costs will also impact earnings.”

Sigma says it values the relationship with the My Chemist/Chemist Warehouse group and will continue to provide operational support to it in accordance with the terms of the current Supply Agreement, which runs until June 2019.

Previous 'Low risk' product reform under question
Next Ground broken on PSA's 'modern pharmacy hub'

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.